【参考文献】
[1]DONIN, JURIANZ K, ZIPOREN L, et al. Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid[J]. Clin Exp Immunol, 2003,131(2):254?263.
[2]FISHELSON Z, DONIN N, ZELL S, et al. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors[J]. Mol Immunol, 2003,40(2?4):109?123.
[3]FONSATTI E, DI GIACOMO A M, MAIO M. Optimizing complement?activating antibody?based cancer immunotherapy: a feasible strategy[J]? J Transl Med, 2004,2(1):21?25.
[4]RAVINDRANATH N M, NISHIMOTO K, CHU K, et al. Cell?surface expression of complement restriction factors and sialyl Lewis antigens in oral carcinoma: relevance to chemo?immunotherapy[J]. Anticancer Res, 2000,20(1A):21?26.
[5]朱新红,高美华,任书荣,等. CD59 基因的突变并真核表达载体的构建[J]. 青岛大学医学院学报, 2008,44(2):95?98.
[6]FROMOROMOWITZ F B, VIOLA M V, CHAO S, et al. Ras p21 expression in the progression of breast cancer[J]. Hum Pathol, 1987,18(12):1268?1275.
[7]HUGHES J, NANGAKU M, ALPERS C E, et al. C5b?9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis[J]. Am J Physiol Renal Physiol, 2000, 278(5):F747?757.
[8]KAWANO M, TSUNODA S, KONI I, et al. Decreased expression of 20 kD homologous restriction factor (HRF20, CD59) on Tlymphocytes in Epstein?Barr virus (EBV)?induced infectious mononucleosis[J]. Clin Exp Immunol, 1997,108(2):260?265.
[9]JONES J, MORGAN B P. Apoptosis is associated with reduced expression of complement regulatory molecules, adhesion molecules and other receptors on polymorphonuclear leucocytes: functional relevance and role in inflammation[J]. Immunology, 1995,86(4):651?660.